General Western Blot Reagents
Abcam Histone H4 (di-methyl R3) Quantification Kit (Colorimetric).
Histone H4 (di-methyl R3) Quantification Kit (Colorimetric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human c-Myc peptide, 1MG
Human c-Myc peptide is a Synthetic blocking peptide. Suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-(1-Naphthyl)ethylenediamine dihydrochloride, coupling agent for spectrophotometric analysis, 10G
MW 259.18 g/mol. Acts as a coupling agent for the spectrophotometric determination of aromatic amines, aminophenols, phenylenediamines, dinitroanilines, chloroanilines, thiols and sulfonamides. Also used in the quantitative analysis of nitrate and nitrite in water samples by colorimetry.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 2'-Deo x ythymidine 5'-monophosphate disodium salt, Deo x yribonucleotide., 250MG
MW 366.2 g/mol, Purity >98%. Deoxyribonucleotide used as a substrate in many molecular biology applications.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Thiol Green Indicator.
Thiol Green Indicator.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Polygodial, TRPA1 agonist, 25MG
MW 234.33 Da, Purity >97%. Selective TRPA1 agonist (EC₅₀ = 400 nM). Antinociceptive in vivo. Inhibits mitochondrial ATPase (IC₅₀ = 15 μM). Antifungal.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Smad2 (phospho S465 + S467) peptide, 1MG
Human Smad2 (phospho S465 + S467) peptide is a Synthetic peptide. >90% purity.
Protein/ Peptide/ Enzyme Synonyms: MADH2, MADR2, SMAD2, Mothers against decapentaplegic homolog 2, MAD homolog 2, Mothers against DPP homolog 2, JV18-1, Mad-related protein 2, SMAD family member 2, hMAD-2, SMAD 2, Smad2, hSMAD2
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Prostratin, PKC activator, 500UG
MW 390.48 g/mol. PKC activator; reactivates HIV-1 latency (IC₅₀ = ~0.5 μM) by PKC dependent NF-κB activation. Downregulates expression of HIV-1 receptor CD4 and its co-receptors CXCR4 and CCR5 in vitro. Non-tumor promoting.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Venlafa x ine hydrochloride, Serotonin-norepinephrine reuptake inhibitor, 50MG
MW 313.87 g/mol, Purity >99%. Serotonin-norepinephrine reuptake inhibitor. Ki values are 82 and 2480 nM for SERT and NET, respectively. Displays 30-fold higher affinity for SERT than NET in vitro. Antidepressant.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AMI 1, protein arginine methyltransferase inhibitor, 5MG
MW 548.5 Da, Purity =99%. Potent, selective and reversible protein arginine methyltransferase inhibitor (IC₅₀ = 1.63 μM). ROS° scavenger with antioxidant effects (IC₅₀ = 8.3 μM). Inhibits arginine in vitro without competing for the AdoMet binding site. Modulates nuclear receptor-regulated transcription in vivo. Cell-permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AMI 1, protein arginine methyltransferase inhibitor, 25MG
MW 548.5 Da, Purity =99%. Potent, selective and reversible protein arginine methyltransferase inhibitor (IC₅₀ = 1.63 μM). ROS° scavenger with antioxidant effects (IC₅₀ = 8.3 μM). Inhibits arginine in vitro without competing for the AdoMet binding site. Modulates nuclear receptor-regulated transcription in vivo. Cell-permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Calcitriol, Vitamin D receptor (VDR) agonist, 250UG
MW 416.6 Da, Purity >99%. Calcitriol, Vitamin D receptor (VDR) agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SMI-4a, ATP-competitive Pim kinase inhibitor, 5MG
MW 273.23 Da. Potent, selective, cell-permeable, ATP-competitive Pim-1 kinase inhibitor (IC₅₀ = 17 nM). Moderately potent against Pim-2 kinase. Selective versus a panel of other serine/threonine and tyrosine kinases. Inhibits the growth of myeloid and lymphoid cell lines. Induces cell cycle arrest in leukemia and prostate cancer cells.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Aeroplysinin (Aeroplysinin-1), antiangiogenic agent, 1MG
MW 338.98 Da, Purity >95%. Potent antiangiogenic agent. Inhibits COX-2 expression. Selectivity for endothelial cells. Able to induce apoptosis via capsase activation, chromatin condensation and nuclear fragmentation. Antibiotic and cytotoxic effects (IC₅₀ = 3 μm) and displays a wide-spectrum antitumor activity. Active in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-161,982, EP4 receptor antagonist, 10MG
MW 654.72 g/mol, Purity >98%. Potent EP₄ receptor antagonist, selective over all other prostanoid receptor family members (Ki values for human receptors are 0.024 (EP₄), 0.71 (TP), 1.90 (EP₃), 5.10 (DP), 5.63 (FP), 6.74 (IP), 19 (EP₁) and 23 μM ( EP₂)). Shows a variety of biological actions including suppression of PGE₂ stimulated bone formation, blocking of cell proliferation and also reverses anti-inflammatory action of PGE₂.
The product is subject to the following: Abcam Restricted Use Statement